SLB Partners with SBI in Brazil for 2019

SLB Partners with SBI in Brazil for 2019

SLB is growing relationships around the globe.  The most recent is a partnership with the Brazilian Society of Immunology (SBI) and their XLIV Congress.  SLB has two member speakers presenting in a special joint session, Sven Brandau and Jose Conejo-Garcia. Learn more about the speakers below and see the opportunities and support SLB is able to provide to members in sharing their science.

Professor Sven Brandau is heading the Experimental and Translation Research Division of the Department of Otorhinolaryngology, Head and Neck Surgery, at the University Hospital Essen, a member of the West German Cancer Center, in Essen, Germany. Professor Brandau studied biology in Hamburg and Los Angeles and performed his PhD work at the Bernhard-Nocht Institute for Tropical Medicine in Hamburg. He was a Post-Doc at the Research Center Borstel, Leibniz Center for Biomedicine, where he became an independent group leader in 2003. Since 2007, he is at the University Duisburg-Essen / University Hospital Essen. Professor Brandau´s main research area is the immunological tumor-host interaction with a focus on myeloid cells. Additional research projects aim at developing novel immunotherapies for head and neck cancer and understanding the role of mesenchymal stromal cells in cancer and infection. Professor Brandau is actively involved in post-graduate teaching and mentoring and serves as a chairperson of “BIOME” (Graduate School for Biomedical Sciences at the Medical Faculty of University Duisburg-Essen). He received several awards for his work on experimental and translational aspects of tumor immunology. Professor Brandau has published more than 120 research papers and well-cited review articles in high-impact biomedical journals. He is currently on the editorial board of Journal of Leukocyte Biology, Innate Immunity, Cancer Immunology Immunotherapy among others. He is an active reviewer for top-tier journals including J Clin Invest, Nat Commun, Blood, Clin Cancer Res and Cancer Research. He is also involved in several ongoing European and global research initiatives aiming at the coordination of research on myeloid cells and their activity in disease (www.Mye-EUNITER.eu).


Dr. Jose Conejo-Garcia is the Chair of the Department of Immunology and co-leader of the Immunology Program at Moffitt Cancer Center. His research focuses on investigating and targeting the mechanisms governing the balance between spontaneous immune control of cancer and malignant progression after immune failure. Dr. Conejo-Garcia completed his medical degree at the University of Zaragoza, in Spain. After a residency in Clinical Chemistry, he completed a PhD in Molecular Medicine from the University of Alcala, also in Spain, in 1998. He then trained as a postdoctoral fellow in pancreatic cancer at the University of Bern, Switzerland, and then moved to Germany to lead a project of the discovery and characterization of antimicrobial peptides. In 2001 he joined the ovarian cancer team at the University of Pennsylvania that shortly afterwards identified for the first time the role of T cell responses in the outcome of ovarian cancer patients. He then joined the Department of Immunology at Dartmouth College, before moving back to the Penn Campus to lead the Tumor Microenvironment and Metastasis Program at The Wistar Institute. Dr. Conejo-Garcia joined Moffitt in November 2016. Dr. Conejo-Garcia has published >120 of recent articles that total >14,000 citations. Those include manuscripts in The New England Journal of Medicine, Cell, Nature, Nature Medicine, Cancer Cell, Immunity and Cancer Discovery. He is the principal investigator of multiple RO1s on the immunobiology of ovarian cancer, and collaborates with other investigators in other funded research projects. Dr. Conejo-Garcia serves as a reviewer on several editorial boards and has completed his tenure as a chartered member of the TTT NIH study section. He has been invited to present or chair sessions at over 30 national and international events including many international locations.